17-acetamido-4-azasteroid derivatives as androgen receptor modulators
Details for Australian Patent Application No. 2004255749 (hide)
International Classifications
Event Publications
22 December 2005 PCT application entered the National Phase
PCT publication WO2005/005606 Priority application(s): WO2005/005606
18 December 2008 Application Accepted
Published as AU-B-2004255749
23 April 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004255754-Warewashing composition and methods for manufacturing and using
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser